Bijan Nejadnik, MD

Chief medical officer, SanBio

Articles by Bijan Nejadnik, MD

Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

February 7th 2021

The chief medical officer at SanBio discussed how the investigational agent SB623 is being studied in TBI and stroke, with future planned studies in Alzheimer disease.

Restoring Function in TBI with Stem Cell Therapy: Bijan Nejadnik, MD

ByBijan Nejadnik, MD

January 24th 2021

The chief medical officer at SanBio discussed how the investigational agent SB623 can fill the void of disease-modifying therapies for TBI.

Bijan Nejadnik, MD

Articles by Bijan Nejadnik, MD

Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

Restoring Function in TBI with Stem Cell Therapy: Bijan Nejadnik, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

NeurologyLive® Friday 5 — November 7, 2025

Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation

Preliminary Phase 2 Data Support Therapeutic Development of Synaptic Regenerative Drug SPG302 in ALS

ALS Qualitative Study Highlights Complexities of Decision-Making Process for Medical Aid in Dying (MAID)

Survey Study Highlights Interest, Motivations Behind Modifier Gene Testing for Huntington Disease